Breast Cancer
📧 Sign up to get email alerts when something new happens for Breast Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2022-06-09Clinical Trial Update: Volatile Anaesthesia and Perioperative Outcomes Related to Cancer Feasibility Study [Phase 4]
Phase 4 clinical trial update on volatile anesthesia and perioperative outcomes in cancer patients; study completed.
-
CLINICAL_TRIALS trial_result · 2022-06-09Clinical Trial Update: Cryoablation Combined With Tirelizumab and Bevacizumab in Liver Metastatic TNBC Patients Failed by Multiline Therapy [Phase 2]
Phase 2 trial update on cryoablation with tirelizumab and bevacizumab in liver-metastatic metastatic breast cancer after multiline therapy; …
-
CLINICAL_TRIALS trial_result · 2022-06-08Clinical Trial Update: Phase I-II Study of Interferon-gamma in Patients With HER-2 Positive Breast Cancer [Phase 1, Phase 2]
Phase I-II study updating on interferon-gamma in HER2-positive breast cancer; the trial has completed with results posted in 2022.
-
CLINICAL_TRIALS trial_result · 2022-06-06Clinical Trial Update: Clinical Study of Chidamide Combined With Chemotherapy in Neoadjuvant Treatment of HR+/ HER2-BC [Phase 2]
Phase 2 study evaluating chidamide plus chemotherapy as neoadjuvant treatment for HR+/ HER2- breast cancer; status and results not disclosed…
-
CLINICAL_TRIALS trial_result · 2022-06-03Clinical Trial Update: Effects of Stellate Ganglion Block on Hot Flashes in Hispanic Women With Breast Cancer [Phase 2]
Phase 2 clinical trial investigating stellate ganglion block for hot flashes in Hispanic women with breast cancer; status terminated with re…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2022-06-03Clinical Trial Update: An Open-Label, Phase Ib/II Clinical Trial Of Cdk 4/6 Inhibitor, Ribociclib (Lee011), In Combination With Trastuzumab Or T-Dm1 For Advanced/Metastatic Her2-Positive Breast Cancer. [Phase 1, Phase 2]
Open-label Phase Ib/II trial evaluating ribociclib with trastuzumab or T-DM1 in advanced/metastatic HER2-positive breast cancer; study compl…
-
CLINICAL_TRIALS trial_result · 2022-06-03Clinical Trial Update: Weekly Utidelone in HER2-negative Inoperable Locally Advanced or Metastatic Breast Cancer [Phase 2]
Phase 2 clinical trial update for weekly Utidelone in HER2-negative inoperable locally advanced or metastatic breast cancer.
-
CLINICAL_TRIALS trial_result · 2022-06-02Clinical Trial Update: PD 0332991 and Anastrozole for Stage 2 or 3 Estrogen Receptor Positive and HER2 Negative Breast Cancer [Phase 2]
Phase 2 trial evaluating palbociclib in combination with anastrozole for Stage 2-3 estrogen receptor-positive, HER2-negative breast cancer; …
-
CLINICAL_TRIALS trial_result · 2022-06-02Clinical Trial Update: Hypofractionated Irradiation At Regional Nodal Area for Breast Cancer Vs Existed Standard Treatment [Phase 3]
Phase 3 trial evaluating hypofractionated irradiation at regional nodal area for breast cancer compared to standard treatment; currently rec…
-
CLINICAL_TRIALS trial_result · 2022-06-01Clinical Trial Update: ARX788 in HER2-positive Breast Cancer Patients With Brain Metastases [Phase 2]
Phase 2 clinical trial update for ARX788 in HER2-positive metastatic breast cancer with brain metastases.
-
CLINICAL_TRIALS trial_result · 2022-05-27Clinical Trial Update: Protocol for Herceptin as Adjuvant Therapy With Reduced Exposure to Chemotherapy (PHARE-C) [Phase 3]
Phase 3 clinical trial protocol investigating Herceptin (trastuzumab) as adjuvant therapy with reduced chemotherapy exposure for HER2-positi…
-
CLINICAL_TRIALS trial_result · 2022-05-27Clinical Trial Update: 1303GCC: Trastuzmab & Pertuzumab With Hormonal Therapy or Chemotherapy in Women Aged 60 and Over. [Phase 2]
A Phase 2 trial of trastuzumab and pertuzumab with hormonal therapy or chemotherapy in women aged 60 and over with metastatic breast cancer …
-
CLINICAL_TRIALS trial_result · 2022-05-25Clinical Trial Update: Radiation Therapy With or Without Optional Tamoxifen in Treating Women With Ductal Carcinoma in Situ [Phase 3]
A Phase 3 trial evaluating radiation therapy with or without optional tamoxifen for treating ductal carcinoma in situ in women has completed…
-
CLINICAL_TRIALS trial_result · 2022-05-25Clinical Trial Update: Therapeutic Dose Monitoring (TDM) of Tamoxifen [Phase 2]
Phase 2 clinical trial update on therapeutic dose monitoring of tamoxifen for breast cancer.
-
CLINICAL_TRIALS trial_result · 2022-05-25Clinical Trial Update: Pantoprazole Prophylaxis Against Delayed CINV for Patients Receiving Breast Cancer Chemotherapy [Phase 2]
A Phase 2 trial evaluating pantoprazole as a prophylaxis against delayed chemotherapy-induced nausea and vomiting in patients receiving brea…
-
CLINICAL_TRIALS trial_result · 2022-05-25Clinical Trial Update: BreCLIM-2 - A RCT Investigating Local Treatment for Breast Cancer Liver Metastases [Phase 3]
Phase 3 trial update for BreCLIM-2 evaluating local treatment for breast cancer with liver metastases; currently recruiting.
-
CLINICAL_TRIALS trial_result · 2022-05-23Clinical Trial Update: Diet, Exercise and Vitamin D in Breast Cancer Recurrence [Phase 3]
A Phase 3 clinical trial evaluating the impact of diet, exercise, and vitamin D on breast cancer recurrence.
-
CLINICAL_TRIALS trial_result · 2022-05-19Clinical Trial Update: Phase 2 Study of Trastuzumab and Etoposide for Her2 Positive Breast Cancer [Phase 2]
Phase 2 study of trastuzumab with etoposide in HER-2 positive metastatic breast cancer was terminated; results posted in 2022.
-
CLINICAL_TRIALS trial_result · 2022-05-19Clinical Trial Update: MBSR During AI Therapy for Breast Cancer [NA]
A completed clinical trial evaluating mindfulness-based stress reduction (MBSR) during AI therapy for breast cancer, with results posted in …
-
CLINICAL_TRIALS trial_result · 2022-05-18Clinical Trial Update: Ribociclib and Aromatase Inhibitor in Treating Older Participants With Hormone Receptor Positive Metastatic Breast Cancer [Phase 2]
Phase 2 clinical trial evaluating ribociclib in combination with an aromatase inhibitor for older adults with estrogen receptor-positive, HE…
-
CLINICAL_TRIALS trial_result · 2022-05-13Clinical Trial Update: Study of Euthyroid Hypothyroxinemia in Metastatic Breast Carcinoma [Phase 2]
A Phase 2 clinical trial evaluating euthyroid hypothyroxinemia in metastatic breast cancer was terminated; results posted in 2022.
-
CLINICAL_TRIALS trial_result · 2022-05-13Clinical Trial Update: Brain Stimulation For Cancer Smokers [NA]
Clinical trial on brain stimulation for cancer patients has completed; results posted in 2022.
-
CLINICAL_TRIALS trial_result · 2022-05-11Clinical Trial Update: A Randomized Phase II Study Of Eribulin Mesylate With or Without Pembrolizumab For Metastatic Hormone Receptor Positive Breast Cancer [Phase 2]
Phase II randomized trial evaluating eribulin mesylate with or without pembrolizumab in metastatic hormone receptor-positive breast cancer c…
-
CLINICAL_TRIALS trial_result · 2022-05-11Clinical Trial Update: Acupuncture in Reducing Chemotherapy-Induced Peripheral Neuropathy in Participants With Stage I-III Breast Cancer [NA]
Clinical trial results for acupuncture to reduce chemotherapy-induced peripheral neuropathy in early-stage breast cancer patients have been …
-
CLINICAL_TRIALS trial_result · 2022-05-10Clinical Trial Update: A Study That Provides Long-term Safety Follow-up and Examines Long-term Exposure to Abiraterone Acetate [Phase 3]
Phase 3 trial update providing long-term safety follow-up and examining long-term exposure to abiraterone acetate in metastatic castration-r…